ImmunoGen Inc (NASDAQ:IMGN)
| 5.57 Delayed Data As of Dec 02 |  -0.04 / -0.71%Today’s Change | 1.95 Today|||52-Week Range 7.07 | +9.11% Year-to-Date |
Latest IMGN News | Press Releases
No recent news for ImmunoGen Inc.
Today’s Trading
| Previous close | 5.61 |
| Today’s open | 5.60 |
| Day’s range | 5.45 - 5.63 |
| Volume | 69,387 |
| Average volume (3 months) | 2,514,084 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 12/02/2020
Growth & Valuation
| Earnings growth (last year) | +41.81% |
| Earnings growth (this year) | +19.84% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +53.93% |
| P/E ratio | NM |
| Price/Sales | 9.20 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NKNantKwest Inc | -0.61 | -6.29% |
| CGENCompugen Ltd | -0.30 | -2.33% |
| BTAIBioXcel Therapeutics... | +2.62 | +6.15% |
| ALECAlector Inc | +0.33 | +2.43% |
Data as of 3:59pm ET, 12/02/2020
Financials
| Next reporting date | February 5, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $82.3M |
| Annual profit (last year) | -$104.1M |
| Net profit margin | -126.57% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
